DeepMatter Group Company

DeepMatter Group provides medical research and development services.

Investors

Technology: Analytics, Biotechnology, Pharmaceutical, Product Research, Software
Industry: AI in Pharma, Early Drug Development
Headquarters: Glasgow, Glasgow City, United Kingdom
Founded Date: 2015-01-01
Employees Number: 11-50
Funding Status: IPO
Acquisitions Number: 2
Investors Number: 1
Estimated Revenue: $1M to $10M
Last Funding Date: 2019-03-18
Last Funding Type: Post-IPO Equity

Visit Website
enquiries@deepmatter.io
https://twitter.com/deepmattergroup
Register and Claim Ownership